Aspire Biopharma Holdings, Inc.
Market Cap
$3.03M
P/E Ratio
-0.03
EPS
$-25.66
Dividend Yield
0.00%
52-Week Range
$0.76 — $35.00
Volume
197.85K
Avg Volume
998.68K
Beta
0.89
P/E (TTM)
-0.03
Forward P/E
—
PEG Ratio
-2.97
P/S (TTM)
1872.34
P/B (TTM)
-18.14
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
3.88%
ROA (TTM)
-11.94%
ROIC
—
Gross Margin
0.46%
Operating Margin
-2066.53%
Net Margin
—
Debt/Equity
-0.12
Current Ratio
0.17
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+7.10%
EPS Growth (5Y)
+5.33%
Sales Growth (3Y)
+0.00%
Sales Growth (5Y)
+0.00%
EPS Est (This Year)
—
EPS Est (Next Year)
—
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$0.01
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
3.46M
Float
2.29M
Free Float %
66.22%
Sector
Healthcare
Industry
Biotechnology
Country
US
Exchange
NASDAQ
IPO Date
2025-02-20
Employees
2
CEO
Kraig T. Higginson
Index Membership
—
Website
https://aspirebiolabs.com
Aspire Biopharma Holdings, Inc. (ASBP) is a healthcare company in the biotechnology industry listed on the NASDAQ. With a market capitalization of $3.03M, a P/E ratio of -0.03, ASBP is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare ASBP against other stocks using dozens of fundamental and technical filters.
Aspire Biopharma Holdings, Inc. (ASBP) has a trailing twelve-month (TTM) P/E ratio of -0.03. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Aspire Biopharma Holdings, Inc. (ASBP) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Aspire Biopharma Holdings, Inc. (ASBP) has a market capitalization of $3.03 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.